Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DILTIAZEM HYDROCHLORIDE INJECTION - Health Canada Drug Approval Details

Approvals/Health Canada/DILTIAZEM HYDROCHLORIDE INJECTION

Authorized

STANDARD

DILTIAZEM HYDROCHLORIDE INJECTION

omega laboratories limited🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 64b629c975f2b543
Company: omega laboratories limited
Type: Standard

Approval Details

Approval Id: 64b629c975f2b543
Drug Approval Canada Name: DILTIAZEM HYDROCHLORIDE INJECTION
Product Name: DILTIAZEM HYDROCHLORIDE INJECTION
Status: Marketed
Status Date: 2021-10-07
Original Market Date: 2021-10-07
Din: 02514095
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 24:28.92
Atc Original: C08DB01 DILTIAZEM
Atc Name: c 08 db 01
Aig Number: 0115863003
Company Name: omega laboratories limited
Company Address: 11177 Hamon, Montreal, Quebec, Canada, H3M 3E4

Active Ingredients

DILTIAZEM HYDROCHLORIDE

5 MG / ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

64b629c975f2b543

Type

Standard

Back to Health Canada Approvals